Back to blog

2026-04-12 · 10 min read

The Complete Guide to Startup Valuation Methods

One of the most confusing parts of startup investing is valuation. A company with no revenue can be worth $5M or $50M depending on the method used. He...

The Complete Guide to Startup Valuation Methods

Understanding How VCs Value Early-Stage Companies

One of the most confusing parts of startup investing is valuation. A company with no revenue can be worth $5M or $50M depending on the method used. Here's how to navigate it.


Why Valuation Methods Matter

Founders need to understand valuation to negotiate fair terms. Investors need to understand valuation to avoid overpaying. Both sides use these methods, which means knowing them gives you an edge in any negotiation.


The 5 Main Valuation Methods

1. Berkus Method

Best for: Pre-revenue startups Developed by: Dave Berkus, angel investor

The Berkus method assigns a dollar value to each milestone achieved:

MilestoneTypical Value
Sound idea (basic value)$100K-$250K
Prototype (reduces technology risk)$100K-$250K
Quality management team (reduces execution risk)$100K-$250K
Strategic relationships (reduces market risk)$100K-$250K
Product launched or committed (reduces product risk)$100K-$250K

Maximum valuation: $2.5M (5 milestones × $500K)

When to use: Seed rounds, solo GP checks under $50K, first-time founders without traction.


2. Scorecard Method (Portland Method)

Best for: Comparing your deal against industry averages Developed by: Angel投资人 association

Step 1: Find the average pre-money valuation for your stage/region/sector.

Step 2: Score your startup against average on these factors:

FactorWeightScore (0-1.0)
Strength of management team30%
Size of opportunity25%
Product/technology15%
Competitive landscape15%
Marketing/sales/channel10%
Need for additional capital5%

Step 3: Multiply average valuation by your weighted score.

Example:

  • Average seed valuation in your sector: $2M
  • Your team is stronger than average (0.8) but product is average (0.5)
  • Score: (0.8×0.30) + (0.5×0.25) + (0.5×0.15) + (0.5×0.15) + (0.5×0.10) + (0.5×0.05) = 0.575
  • Adjusted valuation: $2M × 0.575 = $1.15M

3. Risk Factor Summation Method

Best for: Deals with specific, identifiable risks

Start with a baseline valuation, then add or subtract based on risk factors:

Risk FactorAdjustment
Management risk±$250K
Technology/dev stage risk±$250K
Market risk±$250K
Sales/marketing risk±$250K
Funding risk±$250K
Regulatory/political risk±$250K
Exit/harvest risk±$250K

Example:

  • Base valuation: $2M
  • Strong team (+$250K), unproven tech (-$250K), small market (-$250K)
  • Final valuation: $2M + $250K - $250K - $250K = $1.75M

4. Discounted Cash Flow (DCF)

Best for: Later-stage companies with predictable revenue

DCF is controversial for early-stage because it requires predicting cash flows 5-10 years out. Most early-stage VCs don't use it.

The formula:

Present Value = CF1 / (1+r)¹ + CF2 / (1+r)² + ... + CFn / (1+r)^n

Where:
- CF = Expected cash flow
- r = Discount rate (typically 25-40% for startups)
- n = Number of years

Why it's problematic for startups:

  • Revenue is unpredictable
  • Exit timing is uncertain
  • Terminal value dominates

When it matters: Growth equity ($10M+ rounds), revenue-stage companies.


5. Comparable Transaction Method

Best for: Any stage, but more reliable for later stages

Look at what similar companies sold for recently:

  1. Find 5-10 comparable deals (same sector, stage, geography)
  2. Note the valuation and the metric (revenue, users, ARR)
  3. Calculate the multiple (e.g., 10x revenue)
  4. Apply that multiple to your company

Key multiples by stage:

StageTypical Revenue Multiple
Pre-seedNo revenue - use other methods
Seed2-5x ARR (if ARR exists)
Series A5-10x ARR
Series B8-15x ARR
Growth10-20x ARR

Data sources:

  • Crunchbase
  • PitchBook
  • Mattermark -CB Insights

The Venture Capital Method

Best for: Angels and early VCs

Not a valuation method per se, but a back-of-envelope calculation:

  1. Estimate the company's value at exit (5-7 years out)
  2. Determine your target return (10x for angels)
  3. Work backward to today's valuation

Example:

  • Target: $50M exit in 6 years
  • Target return: 10x
  • Your check: $500K
  • Pre-money valuation: $5M - $500K = $4.5M

Decision Matrix: Which Method to Use

StagePrimary MethodSecondary
Pre-seed (<$500K)BerkusRisk Factor
Seed ($500K-$2M)ScorecardBerkus
Series A ($2M-$10M)ComparableDCF
Series B+ComparableDCF

The Math Problem with Post-Money SAFEs

Founders often confuse pre-money and post-money valuations with SAFEs.

Simple SAFE (no cap):

  • Investment: $100K
  • Post-money valuation: $4M
  • Your ownership: $100K / $4M = 2.5%

SAFE with cap:

  • Investment: $100K
  • Cap: $2M
  • Post-money: $2M + $100K = $2.1M
  • Your ownership: $100K / $2.1M = 4.76%

The dilution trap: If the next round is at $6M pre-money:

  • Previous SAFE holders at $2M cap get: $2M / $6M = 33% (capped)
  • New investors get: 67%
  • Founder gets: diluted from ~95% to ~63%

Red Flags in Valuation Discussions

For founders:

  • Investor claims "this is just how it's done" without explanation
  • Valuation based on "market standards" without data
  • Down round disguised as "structured preferred"
  • Liquidation preference > 1x

For investors:

  • Pre-money valuation that doesn't match comparable transactions
  • Founder refusing to disclose previous raise terms
  • Circular valuations (using this round to value itself)

How to Negotiate Valuation

  1. Know your BATNA - What's your alternative if this deal falls through?

  2. Lead with data - Use comparable transactions to justify your number

  3. Consider the whole term sheet - A higher valuation with worse terms can be worse than a lower valuation with founder-friendly terms

  4. Think about signal - Taking a down round signals distress; taking a flat round signals steady progress

  5. Know when to fold - If valuation is non-negotiable and you're overvalued, walking away is sometimes the right move


Key Takeaways

  1. No single method is correct - Use 2-3 methods and triangulate
  2. Stage matters - Pre-seed uses different methods than Series B
  3. Negotiation is part of the method - The "correct" valuation is usually a range
  4. Terms matter as much as valuation - A 2x liquidation preference changes everything
  5. Document everything - Cap table confusion is a startup killer

Tools and Resources


This article is part of SoloAnalyst's due diligence framework. For automated valuation analysis, try our free tool.

Run this framework on your next inbound deal.

SoloAnalyst turns public signals into a fast, structured memo before your first founder call.